A randomized phase III trial of second-line chemotherapy comparing CPT-11 alone versus S-1 plus CPT-11 combination therapy in advanced gastric cancer refractory to first-line therapy with S-1 (JACCRO GC-05).

Authors

null

Kazuhiro Nishikawa

Osaka National Hospital, Osaka, Japan

Kazuhiro Nishikawa , Kazuaki Tanabe , Masashi Fujii , Chikara Kunisaki , Akihito Tsuji , Nobuhisa Matsuhashi , Akinori Takagane , Tetsuro Ohno , Tomono Kawase , Mitsugu Kochi , Kazuhiro Yoshida , Yoshihiro Kakeji , Wataru Ichikawa , Keisho Chin , Masanori Terashima , Masahiro Takeuchi , Toshifusa Nakajima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

00639327

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 87)

DOI

10.1200/jco.2014.32.3_suppl.87

Abstract #

87

Poster Bd #

C25

Abstract Disclosures